Press Releases
Darunavir Market to Set Phenomenal Growth from 2018 to 2026

Darunavir Market

, 17 April 2019 -- Darunavir market is expected to grow at a major CAGR due to the ability to growing number of patients with HIV-1 infection especially in low and middle income countries. Moreover, scientific improvements, and increase in number of patients worldwide will also support the darunavir (prezista) market growth.

The need for treatment of human immunodeficiency virus (HIV 1), arises primarily from the increasing number of infected patients, since they can led to cause acquired immune deficiency syndrome (AIDS). Darunavir (Prezista) is engaged in blocking enzyme called protease which is involved in the reproduction of HIV. In addition, it is given in combination with other antiviral drugs, which reduces the amount HIV in the blood and maintain it at low level. Moreover, it does not cure HIV infection but it may delay the damage to the immune system.

Read Report Overview:

Darunavir (Prezista) is particularly utilized for the treatment of HIV-1 infection in ##### and pediatric patients with 3 years of age and above. In addition, darunavir is available in different range of dosage form i.e. tablet 75 mg to 800 mg, which allows to manage the level of resistance and cross-resistance of combination therapy. Darunavir is not solely administered, it is co-administered with ritonavir and with other antiretroviral agents for better efficacy and results in maintaining the level of HIV-1 in the human blood. Furthermore, before the initiation of prezista certain test are essential includes treatment history, genotypic and phenotypic tests to asses drug susceptibility of the HIV-1 virus. Prezista are expected to grow at a high rate owing to increase in patient number with HIV infection. Darunavir market is expected to grow at a major CAGR due to the ability to growing number of patients with HIV-1 infection especially in low and middle income countries. Moreover, scientific improvements, and increase in number of patients worldwide will also support the darunavir (prezista) market growth. However, hepatotoxicity, severe skin reactions and resistance and cross-resistance are certain challenges which may hamper the market growth of darunavir (prezista).

The darunavir (prezista) market has been segmented by formulation, by dosage, and by geography. In terms of formulation, the darunavir (prezista) has been categorized into solid dosage formulation and suspension formulation. Hence, darunavir (prezista) in these preparations would play a major role in the treatment of human immunodeficiency virus (HIV 1) in ###### and pediatrics above 3 years. Based on dosage, the darunavir (prezista) market has been segmented into oral suspension 100 mg/ml, tablets 75 mg, tablet 150 mg, tablet 600 mg, and tablet 800 mg.

Obtain the Report Brochure:

Geographically, North America was observed to be the largest darunavir (prezista) market due to extensive research and developments in the region. Countries such as the U.S. and Canada have been successful in the use of darunavir (prezista), which as a result would boost the market growth. Moreover, presence of healthcare infrastructure, promising government initiatives in implementing darunavir (prezista) in the HIV-1 infection treatment and constantly improving reimbursement scenario would further propel the darunavir (prezista) market growth. Europe was observed to be the second largest market in the darunavir owing to enhanced healthcare processes and implementation of high healthcare concerns in the region. The major factor that would drive the market in Asia Pacific include the increased number patients infected to HIV in the region. China, Japan and India are the most developing countries in the region and hence would fuel the market growth for darunavir (prezista). South American countries such as Brazil and Mexico are the regions that have significant potential for growth due to evolving medical structure, and high disposable income.

The major players operating in this darunavir (prezista) market include Janseen Pharmaceuticals, Inc., Inc, Teva Pharmaceuticals, Lupin Pharmaceuticals, Inc., Mylan Pharmaceutical Company, Hetero Healthcare Ltd. among other significant players worldwide.

Request for the Discount on the Report:

About Us:

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.


Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

# # #

Submitted by hawer on Wednesday, 17 April 2019 at 10:29 PM
Category: Health Care & Medical
Related News

Coronary Stents Market: Increase in Geriatric Population to Drive Demand
Friday, 19 Apr 2019

Wearable Medical Devices Market - Rising Number of Sports and Fitness Enthusiasts to Boost the Deman
Friday, 19 Apr 2019

Catheters Market - Increasing Demand for Minimally Invasive Surgeries to Spur the Demand
Friday, 19 Apr 2019

Fragment-based Drug Discovery Market Will be Worth US$1.15 bn by 2023
Friday, 19 Apr 2019

Homeopathy Product Market is Projected to be Worth US$17,486.2 mn by 2024
Friday, 19 Apr 2019

Related Events

3rd Annual NASH Summit | April 22-25, 2019 | Boston, MA
Monday, 22 Apr 2019

Rx Drug Abuse and Heroin Summit
Monday, 22 Apr 2019

European NeoAg Summit 2019
Tuesday, 23 Apr 2019

Wednesday, 24 Apr 2019

8th Digital Marketing for Medical Devices West
Wednesday, 24 Apr 2019

Latest News SEO Agency to Boost Your Website Traffic with Latest Technology and Smart SEO Techn
Sunday, 21 Apr 2019

Four Years of Despair Book Launch
Sunday, 21 Apr 2019

Sunday, 21 Apr 2019

Infographic presenting the 6 Steps to Sell a House in Wisconsin
Sunday, 21 Apr 2019

Benefits of the Amazing Red Tea for Weight Loss in the Healthiest Way
Sunday, 21 Apr 2019

Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2019
Today is Sunday, 21 April 2019

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Consumer Technology
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
News & Media
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!

Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.

  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.

  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Upcoming Events
  • Palo Alto Networks: Palo Alto Networks Next Generation Firewall Hands-on Seminar
  • DOZ Live Inspirational Conference (DOZ Live)
  • 3rd Annual NASH Summit | April 22-25, 2019 | Boston, MA
  • Rx Drug Abuse and Heroin Summit
  • European NeoAg Summit 2019

  • Latest Jobs
    Sorry, there are currently no entries posted here.